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Abstract
Background:  The intracellular signaling events of the Bone Morphogenetic Proteins (BMPs)
involve the R-Smad family members Smad1, Smad5, Smad8 and the Co-Smad, Smad4. Smads are
currently considered to be DNA-binding transcriptional modulators and shown to recruit the
master transcriptional co-activator CBP/p300 for transcriptional activation. SNIP1 is a recently
discovered novel repressor of CBP/p300. Currently, the detailed molecular mechanisms that allow
R-Smads and Co-Smad to co-operatively modulate transcription events are not fully understood.
Results:  Here we report a novel physical and functional link between Smad1 and the 26S
proteasome that contributes to Smad1- and Smad4-mediated transcriptional regulation. Smad1
forms a complex with a proteasome β  subunit HsN3 and the ornithine decarboxylase antizyme
(Az). The interaction is enhanced upon BMP type I receptor activation and occur prior to the
incorporation of HsN3 into the mature 20S proteasome. Furthermore, BMPs trigger the
translocation of Smad1, HsN3 and Az into the nucleus, where the novel CBP/p300 repressor
protein SNIP1 is further recruited to Smad1/HsN3/Az complex and degraded in a Smad1-, Smad4-
and Az-dependent fashion. The degradation of the CBP/p300 repressor SNIP1 is likely an essential
step for Smad1-, Smad4-mediated transcriptional activation, since increased SNIP1 expression
inhibits BMP-induced gene responses.
Conclusions: Our studies thus add two additional important functional partners of Smad1 into
the signaling web of BMPs and also suggest a novel mechanism for Smad1 and Smad4 to co-
modulate transcription via regulating proteasomal degradation of CBP/p300 repressor SNIP1.
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Background
The bone morphogenetic proteins (BMPs) form a sub-
family of the Transforming Growth Factor β  (TGF-β ) su-
perfamily [1–4]. Members of the BMP family were
initially identified by their ability to induce ectopic bone
formation [4]. Functional characterization of BMPs and
the cloning of new BMP family members have revealed
that BMPs not only regulate bone formation and homeos-
tasis but also function as morphogenetic factors for many
other tissues and organs [2]. The critical regulatory roles of
BMPs during early embryogenesis, such as neurogenesis,
mesoderm formation and patterning, are also well-recog-
nized [1–3].
Like other members of the TGF-β  superfamily, BMPs in-
duce intracellular signaling via heteromeric complexes of
the type I and type II serine-threonine kinase receptors
[5,6]. The Smad family proteins are now known to func-
tion as key signal transducers downstream of the TGF-β
family type I receptors [6–8]. The activated BMP type I re-
ceptors directly recruit and phosphorylate a set of cyto-
plasmic Smad proteins that are specific for the BMP type I
receptors. Three such BMP type I receptor-regulated
Smads, Smad1, 5 and 8, have been identified [9]. Among
them, Smad1 has been studied most extensively. The
phosphorylation of Smad1 at the carboxylterminal SSVS
motif triggers the release of Smad1 from the receptor, the
formation of homo-oligomers of Smad1 and hetero-oli-
gomers of Smad1 and Smad4, and the subsequent nuclear
translocation of both Smad1 and Smad4 [6,9,10]. In the
nucleus, Smad1 and Smad4 function as DNA-binding
transcriptional regulators [9]. However, there is a unique
feature in Smad-regulated transcription. Instead of inde-
pendently binding to specific DNA sequence to regulate
transcription, Smads are now considered to be transcrip-
tional modulators since their ability to regulate transcrip-
tion is dependent, in most cases, on their physical
interaction with other nearby DNA-binding transcription
factors[11]. Thus, one of the fundamental questions in
understanding Smad-regulated transcription is how
Smads function as transcription modulators.
The transcriptional regulatory activities of Smad1 in the
nucleus are associated with its ability to directly bind to
DNA [12], its interaction with other DNA-binding tran-
scription factors, such as OAZ, SIP1 and Hoxc-8 [13–15],
and also its interaction with the master transcriptional co-
activator CBP/p300 [16]. Smad4 is an essential functional
partner in Smad-regulated transcription and also interacts
with CBP/p300 via a domain within the central linker re-
gion named as SAD (Smad Activation Domain) [13].
Since CBP/p300 has intrinsic histone acetyltransferase
(HAT) activity and participates in chromatin remodeling,
the recruitment of CBP/p300 into the DNA-binding com-
plexes of Smad1 and Smad4 is likely a critical step in
Smad-regulated gene activation. However, our current
knowledge of the molecular events involved in the recruit-
ment of CBP/p300 and other transcriptional co-activators
or co-repressors by Smads is still very limited. Further-
more, the molecular mechanisms underlying the cooper-
ative functional partnership between Smad1 and Smad4
during transcriptional regulation is not yet understood.
Protein-protein interaction plays key roles in signal trans-
duction. To gain further understanding of the signaling
mechanisms of Smad1, we carried out a "blind" search for
proteins that bind specifically to Smad1 using the yeast
two-hybrid system. Characterization of these interactors
reveals an unexpected physical and functional link be-
tween Smad1 and the proteasome-mediated degradation
pathways. The 26S proteasome is responsible for the bulk
turnover of cytoplasmic and nuclear proteins in eukaryot-
ic cells and also plays a key role in the regulation of cell
cycle, signal transduction, transcription as well as antigen
presentation [17–21]. Most of the known proteasomal
substrates are marked and targeted to proteasome by
ubiquitination [17,19,20]. Ubiquitination, however, is
not an obligatory step for substrate targeting to proteas-
ome [17,18,20]. The degradation of the ornithine decar-
boxylase (ODC), the rate-limiting enzyme for polyamine
synthesis, involves a protein named antizyme (Az), which
binds and targets ODC to 26S proteasome for degradation
[18]. However, ODC has remained an "orphan" in Az-de-
pendent proteasomal degradation.
Interestingly, both ubiquitin and Az were isolated from
the yeast two-hybrid system as Smad1 interactors. Further-
more, an integral component of proteasome, HsN3 [22–
24], which is a β  subunit of the 20S catalytic core, was also
isolated as a strong and specific Smad1 interactor. Func-
tional characterization of the interaction between Smad1,
Az and HsN3 in the signaling pathways of BMPs led us to
find a novel functional link between Smad1 and proteas-
ome-mediated degradation events, through which a novel
CBP/p300 repressor, SNIP1 [25], is removed to allow the
transcriptional activation of BMP-responsive genes.
Results
The isolation of Smad1 interacting proteins reveals a phys-
ical interaction between Smad1 and components in pro-
teasome-mediated degradation pathways
We applied the yeast "Protein Trap" system to isolate
Smad1 interactors[26,27]. Full length Smad1 was fused
with the DNA-binding domain of LexA to serve as bait. A
human fetal brain cDNA library with cDNA inserts fused
with the transcriptional activation domain B42 was used
for the screen. From screening one million cDNA clones,
40 clones exhibited strong activation of both of the re-
porter genes (LacZ and Leu2). Thirteen different cDNA in-
serts were identified from these 40 clones. The ability ofBMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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these thirteen candidate Smad1 interactors to bind
Smad1, Smad2, Smad3 and Smad4 were directly tested in
the yeast two-hybrid system (Fig. 1A). Among the thirteen
isolated Smad1 interactors, only clones 13, 17, 19 and 21
bind Smad2, whereas only clones 1, 17 and 21 exhibit
strong interaction with Smad3. Only one clone (clone 17)
among the thirteen clones interacts with Smad4. Interest-
ingly, this clone encodes a truncated Smad1 lacking its
MH1 domain. Such an interaction is consistent with the
known ability of Smad1 to bind Smad4 upon its activa-
tion in mammalian cells [9].
The identities of the thirteen interactors are summarized
(Fig. 1B, top panel). We divided the interactors into three
groups (Fig. 1B, top panel). The first group contains pro-
teins that have a functional link to the degradation path-
ways of the 26S proteasome. They are: two ubiquitin
precursors UBA80 (clone 1) and UBA52 (clone 21), the
ornithine decarboxylase antizyme (Az) (clone 15) and the
proteasome β  subunit HsN3 (clone 18). The second group
contains four known proteins: GST (clone 13), MBP-1 (c-
Myc promoter Binding Protein, clone 14) [28], Smad1
(clone 17), TAG (Tumor Associated Gene, clone 31) [29]
and PAG (Proliferation Associated Gene, clone 35) [30].
The third group contains four novel proteins: clone 19,
12, 27 and 28, which we named as SNIP1, SIP2, SIP3 and
SIP4, respectively. The functional characterization of
clone 19 (SNIP1) as a novel CBP/p300 interactor and re-
pressor has been reported recently in the signaling path-
ways of TGF-β  [25]. The functional characterization of
clone 12 (SIP2) as a new member of the sorting nexin
family member has also been reported [31]. Studies of the
novel protein SIP3 will be reported separately (Paralkar et
al, manuscript in preparation).
We were intrigued by the fact that Smad1 binds to Ub, Az
and HsN3, all of which are involved in proteasome-medi-
ated degradation pathways, as illustrated in Fig. 1B, bot-
tom panel. The well-known ubiquitin-dependent
pathway involves the covalent attachment of ubiquitin to
substrate proteins to form polyubiquitin chain, which
then targets the marked substrates to proteasome for deg-
radation [17,19,20]. The ubiquitin-independent pathway
is not well defined, but involves targeting proteins other
than ubiquitin. The best-characterized example of ubiqui-
tin-independent degradation is the degradation of orni-
thine decarboxylase (ODC), which is dependent upon
ODC interaction with the targeting protein antizyme (Az)
[18]. How ubiquitinated substrates or Az-bound ODC is
recognized by the 26S proteasome is not well understood.
HsN3 is a β  subunit of the 20S core of the 26S proteasome
and previously has also been implicated in targeting its in-
teracting protein p105 subunit of NF-κ B into the 26S pro-
teasome [22–24,32]. Thus, it is interesting that Smad1 can
bind to two types of proteasome substrate-targeting pro-
teins (ubiquitin and Az) as well as a proteasome compo-
nent (HsN3) that has a possible substrate-targeting role.
Studies were then carried out to further characterize
Smad1 interaction with HsN3 and Az in mammalian cells
and test a functional role of these interactions in the sign-
aling pathways of BMPs as detailed below.
Figure 1
The isolation of Smad1 interacting proteins suggests
a functional link between Smad1 and the 26S protea-
some-mediated protein degradation.A. Yeast two-
hybrid test of the interaction specificity between thirteen iso-
lated Smad1 interactors and Smad1, Smad2, Smad3 and
Smad4. The "Protein Trap" system was used for the test [27].
Yeast EGY48 (leu2,his3,trp1,ura3) was first transformed with
LexA fusion constructs of Smads in pEG202 vector and then
transformed again with each of the thirteen different cDNA
clones in pJG4-5 vector. The transformants were streaked
onto selective plates of either galactose/raffinose (top) or
glucose (bottom) lacking uracil, histidine and tryptophan (U-
H-W-) but containing X-Gal. The expression of the cDNA
encoded fusion proteins is under the control of the GAL1
promoter. The light blue detected on the glucose plates
reflects a basal level of transcriptional activation by the LexA-
Smad fusion proteins. B. The thirteen Smad1 interactors
were grouped into three groups based upon their known
functions (top panel). The four clones that have functions
along the proteasome-mediated degradation pathways are
marked by different colors in the top panel and matches with
the colored symbol in the bottom panel, which illustrates the
proteasomal targeting pathways. See text for details.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Smad1 interacts with prosequence-containing HsN3 but 
not processed HsN3 in the 20S proteasome and the activa-
tion of the BMP type I receptor enhances the interaction
We first focused upon the physical interaction between
Smad1 and HsN3. As one of the seven β  subunits of the
20S proteasome, the newly translated HsN3 has an N-ter-
minal 44 amino-acid prosequence, which is processed
upon the complete assembly of HsN3 into the mature 20S
proteasome [22–24]. The assembly of the 20S proteasome
involves multiple steps and the formation of assembly in-
termediates [33–36]. As illustrated in Fig. 2A, seven single
α  subunits first form the α  ring, which serves as the tem-
plate for seven β  subunits to assemble the β  ring. The half
proteasomes containing one α  and one β  rings are further
assembled into 20S proteasome, a process involving the
proteolytic cleavage of the prosequences of five β  subu-
nits, including HsN3. The 20S proteasome then combines
with two 19S regulatory complex to form the 26S protea-
some, which is the degradation machinery responsible for
both ubiquitin-dependent and ubiquitin-independent
degradation [37]. The prosequences of the proteolytic β
subunits are important to keep the proteolytic sites inac-
cessible to the substrates. In addition, the prosequences
still bind to the β  subunits after its cleavage and may serve
important chaperon roles for the β  subunits to be properly
positioned into assembly complex. This was demonstrat-
ed previously by artificially removing the prosequence of
one β  subunit and showed that the assembly of this β  sub-
unit is completely blocked while separate expression of
the prosequence was enough to restore the assembly[19].
The defective assembly of a β  subunit due to the lack of
prosequence is illustrated in Fig. 2B.
To follow up the observed interaction between Smad1
and HsN3 in mammalian cells, we first constructed three
HsN3 expression constructs. The first construct contains a
Flag-epitope placed at the C-terminus of HsN3 (N3-F),
since the C-terminus of HsN3 is not buried inside of the
mature proteasome, according to the crystal structure of
HsN3 [38]. The second and the third constructs contain
either the Flag or the T7 epitopes placed at the N-terminus
of HsN3 (F-∆ N3, T7-∆ N3). Since the N-terminal prose-
quence of HsN3 is processed upon assembly into the 20S
proteasome, we deleted the prosequence of HsN3 and re-
placed it with the Flag/T7-epitopes to assure that the
epitopes will not be lost due to prosequence-processing.
We first expressed these constructs into COS1 cells and ex-
amined their expression and assembly properties by im-
munoprecipitation of each expressed protein from
metabolically labeled COS1 cells (Fig. 2C). Multiple en-
dogenous proteins from COS1 cells were co-precipitated
with Flag tagged wild type HsN3 (Fig. 2C, lane 2), while
much few proteins were detected in the immunoprecipi-
tates of the two deletion versions of HsN3 lacking the
prosequence (Fig. 2C, lanes 3 & 4). The predominant
band in the immunoprecipitation of wild type HsN3 is
the prosequence-containing HsN3 (Pro-N3-F), as indicat-
ed by its molecular weight and the ability of anti-Flag an-
tibody to detect it in a parallel Western blot. The other
predominant band immediately below Pro-N3-F is the
mature form of Pro-N3-F, as indicated by the ability of
this band to be also detected by anti-Flag on the Western
blot and by its co-migration with the deletion version of
N3 lacking the prosequence (F-∆ N3 in lane 3). The rest of
the proteins detected in the immunoprecipitates of wild
type full length HsN3 (Fig. 2C, lane 2) are predominantly
different subunits of the 20S proteasome and 19S regula-
tors, as indicated by their molecular weights and their
ability to be recognized by anti-20S and anti-19S antibod-
ies (data not shown). The lack of most of these endog-
enous proteasome components in the
immunoprecipitates of the two deletion version of HsN3
whose prosequences have been artificially removed via
deletions indicates that the prosequence of HsN3 is also
important for its successful assembly into the mature 20S
proteasome. The slight different band patterns detected in
the immunoprecipitates of F-∆ N3 and T7-∆ N3 suggests
that different epitope tags may influence N3 interaction
with endogenous proteasome components. Since mature
β  subunits are only found in the 20S proteasome [19], the
detection of the mature form of the Flag-tagged HsN3 as-
sured us that the exogenous Flag-tagged HsN3 proteins
are normal in their ability to be incorporated into the 20S
proteasome.
We then tested the ability of HsN3 to bind Smad1 in
COS1 cells by transient transfection followed by immu-
noprecipitation assays. To monitor the co-precipitation of
Smad1 with HsN3-containing proteasome complexes,
immunoprecipitation were carried out using total cellular
proteins from metabolically labeled COS1 cells. Upon the
immunoprecipitation of Smad1, only the full-length
HsN3 protein, but not the processed mature form of
HsN3, was detected to co-precipitate with Smad1 (Fig. 3A,
right panel, lane 4). Although the overexpressed HsN3 is
associated with many other endogenous proteasome
components from the COS cells (Fig. 3A, left panel, lane
4), these endogenous proteins also were not detected in
the immunoprecipitates of Smad1 (Fig. 3A, right panel,
lane 4). Thus, Smad1 only binds the prosequence-con-
taining HsN3 (pro-N3-F), which, as illustrated in Fig. 2A,
only exists transiently before the formation of 20S protea-
some. Our domain mapping studies in yeast two-hybrid
system have previously suggested that the MH2 domain of
Smad1 is necessary for its interaction with HsN3 [39].
Thus we also tested the interaction between HsN3 and
Smad1 MH2 domain. Pro-N3-F was also detected in the
immunoprecipitates of Smad1MH2 (Fig. 3A, right panel,
lane 3), suggesting that the MH2 domain is sufficient to
bind to the pre-assembled HsN3.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Figure 2
The expression and assembly of HsN3 in transfected COS1 cells.A. A cartoon that illustrates the multiple steps
known to involve in the assembly of the 26S proteasome. See text for details. B. A cartoon that illustrate the importance of β
subunit prosequence in proteasome assembly. See text for details. C. The different assembly properties of wild type HsN3 and
mutant HsN3 lacking its prosequence in transfected COS1 cells. COS1 was transfected with N3-F, a construct that contains
the full-length wild type HsN3 and a Flag-epitope at the C-terminus (lane 2), or with F-∆ N3 (lane 3), a construct that lacks its
prosequence at the N-terminus, instead contains an N-terminal Flag-epitope, or with T7-∆ N3, a construct that similarly lacks
the prosequence but contains an N-terminal T7-epitope (lane 4). Cells were metabolically labeled with 35S-methionine for 4
hrs before cells were harvested and analyzed by immunoprecipitation, as indicated. The two major bands in lane 2 were
detected by Western blot using anti-Flag and marked out as prosequence-containing HsN3 (Pro-N3-F) and mature HsN3
(mature N3-F). The endogenous proteasome components at the molecular weight range of 19S proteasome (marked by small
dots) or 20S proteasome in lane 2 are marked with brackets. A distinct set of eight bands that commonly detected to be asso-
ciated with F-∆ N3 or T7-∆ N3 is marked with short lines at the right side of the panel. The transfection efficiency was moni-
tored by co-transfection with a GFP construct. Equal transfection efficiency (70–80%) among different samples in a single
experiment was the pre-requisite for metabolic labeling and the subsequent immunoprecipitation assays. Equal total amount of
proteins were used for immunoprecipitation.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Figure 3
Smad1 interacts with the pre-assembled HsN3 and BMP type I receptor activation enhances the interaction.A.
The prosequence-containing form (pre-assembled form) of HsN3 interacts with Smad1 or the MH2 domain of Smad1
(Smad1C) in COS cells upon co-expression. COS cells were transiently transfected with the indicated plasmids and metaboli-
cally labeled with 35S-methionine for the last 4 hrs. Cell lysates were immunoprecipitated with either anti-Flag to detect HsN3
(left panel) or with anti-T7 to detect Smad1 and Smad1C (right panel). The co-precipitated prosequence-containing HsN3 in
both panels is marked by a filled arrow and labeled as "Pro-N3-F" and a cartoon symbol shown in Fig. 2A. The mature HsN3 is
marked by an open arrow and labeled by a cartoon symbol with the cleaved prosequence next to the mature HsN3. B. The
activation of BMP type I receptor ALK3 enhances the interaction between Smad1 and the pre-assembled HsN3. Methods are
same as in Fig. 2C.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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To test whether the observed interaction between Smad1
and Pro-N3-F, the pre-assembled form of HsN3, is regu-
lated by BMP type I receptor activation, we co-expressed
Smad1 and HsN3 with a mutant type I receptor,
ALK3Q233D. ALK3Q233D is constitutively active in in-
ducing downstream signaling events in the absence of
BMPs or the type II receptor [40]. The co-expression of
ALK3Q233D with Smad1 and HsN3 significantly in-
Figure 4
Western blot analyses to confirm Smad1 interaction with prosequence-containing HsN3 and the detection of
Smad1 interaction with HsN3 assembly intermediates.A&B. Immunoprecipitation and Western blot analyses of spe-
cific interaction between Smad1 and the prosequence-containing HsN3. COS1 cells were transfected with the indicated full
length HsN3 and Smad1 or Smad2 and the interaction was analyzed via immunoprecipitation followed by Western blot, as indi-
cated. Lactacystin treatment (indicated in panel B., lane 4) was 8 hrs. The co-precipitated prosequence-containing HsN3 and
the naturally processed mature HsN3 is marked and labeled similarly as in Fig. 3. "Ig.G.L" represents antibody light chain. C.
The interaction between Smad1 and prosequence-containing HsN3 is not dependent upon the prosequence of HsN3. T7-∆ N3:
T7-tagged deletion mutant of HsN3 that lacks the prosequence. To distinguish this form of mutant HsN3 from the naturally
processed HsN3 in panels A & B, T7-∆ N3 is also labeled with a cartoon symbol that matches the assembly defective β  subunit
shown in Fig. 2B. D.-F. Smad1 and Smad1C (MH2 domain) both bind to HsN3-associated proteasome assembly intermediates
accumulated as a result of artificial removal of the prosequence of HsN3. COS1 cells were transiently transfected with the indi-
cated constructs, labeled with 35S-methionine for 4 hrs before cells were harvested and analyzed by immunoprecipitation, as
indicated. The eight distinct bands associated with T7-∆ N3 as shown in Fig. 2C is again marked here in lanes 2 and 4 in panel E.
An additional four distinct small molecular weight bands are also detected in these two lanes, as marked by "?". The identities
of these proteins are unknown, but they were always detected only when Smad1C and ∆ N3 were co-expressed.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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creased the amount of the pre-assembled HsN3 that was
co-precipitated with Smad1 (Fig. 3B, right panel, compare
lanes 2 & 3). Smad1 was also detected in the immunopre-
cipitates of HsN3 (Fig. 3B, lanes 2 & 3). Since equal trans-
fection efficiency was monitored and equal total proteins
were used for the immunoprecipitation, the increased sig-
nals of pro-N3-F and its associated proteins in Fig. 3B,
lane 3, left panel, may reflect an increased stability of
HsN3 due to complex formation with Smad1, upon BMP
receptor activation.
The association between Smad1 and HsN3 was further
confirmed by immunoprecipitation followed by Western
blot analyses. As shown in Fig. 4A and Fig. 4B, Pro-N3-F
was specifically detected in the immunoprecipitates of
Smad1 but not those of Smad2. When the activated BMP
type I receptor was co-expressed with Smad1 and HsN3, a
reduction of Smad1 level was detected and the reduction
is blocked by the addition of the proteasome inhibitor lac-
tacystin, indicating the proteasomal degradation of
Smad1 induced by BMP type I receptor activation. This
phenomenon was further investigated and confirmed in a
separate study [39]. The interaction between Pro-N3-F
and Smad1 was also stabilized in the presence of proteas-
ome inhibitor lactacystin (Fig. 4B, lanes 4). Western blot
using anti-26S proteasome was also carried out to show
that only Pro-N3-F, not mature N3, nor other proteasome
components, was co-precipitated with Smad1 (data not
shown).
Smad1 can interact with prosequence-deleted HsN3 in 
HsN3 assembly intermediates
The lack of mature HsN3 and other proteasome compo-
nents in the immunoprecipitates of Smad1 could be me-
diated by two different mechanisms. First, the
prosequence of HsN3, which is processed from the ma-
ture HsN3, is necessary for Smad1 to bind to HsN3. Sec-
ond, the final maturation of the 20S proteasome resulted
from the assembly of two half proteasomes into the four
stacked ring structure could trap the already bound
Smad1 inside the proteasome for rapid degradation or
lead to the dissociation of Smad1 from mature 20S pro-
teasome due to the inaccessibility of Smad1 binding site
on the incorporated HsN3. We first tested the role of the
prosequence of HsN3 in binding to Smad1. As shown in
Fig. 4C, artificial removal of the prosequence of HsN3
(∆ N3) did not abolish Smad1 binding to HsN3. In fact,
the interaction between ∆ N3 and Smad1 was even strong-
er when directly compared with the interaction between
wild type HsN3 and Smad1 (data not shown). Thus,
HsN3 does not require the prosequence to bind Smad1.
Since we have shown that artificial removal of the prose-
quence of HsN3 leads to a blockage of the normal assem-
bly of HsN3 into the mature proteasome (Fig. 2C), we
suspect that the detected strong signals of ∆ N3 from
Smad1 immunoprecipitates reflect the accumulated HsN3
within the defective assembly intermediates, as illustrated
in Fig. 2B. To test this possibility, we directly compared
the ability of Smad1 MH2 domain to bind wild type
HsN3 and prosequence-less mutant HsN3 in metabolical-
ly labeled COS 1 cells (Fig. 4D & 4E). When COS1 cells
were expressing wild type HsN3, only the Pro-N3-F was
detected in the immunoprecipitates of Smad1MH2 (Fig.
4D, lane 4). When COS1 cells were expressing the mutant
HsN3 lacking the prosequence, the mutant N3 (∆ N3) and
∆ N3 associated endogenous proteins were detected in the
immunoprecipitates of Smad1MH2 (Fig. 4E, lane 4). In
addition, four distinct small molecular weight proteins
with unknown identity were also recruited into the ∆ N3/
MH2-containing complex (Fig. 4E, lane 2 and lane 4).
These four bands were specifically detected only when
Smad1MH2 and ∆ N3 were co-expressed. When
Smad1MH2 was replaced with full length Smad1, the
∆ N3-containing complex was also detected in the immu-
noprecipitates of Smad1 (Fig. 4F). Thus, a blockage of
HsN3 assembly resulted from deleting the prosequence of
HsN3 allows the detection of a stable complex between
Smad1 and HsN3 assembly intermediates. These data sug-
gest that Smad1 interacts with HsN3 transiently when
HsN3 is either in single Pro-HsN3 form, or in Pro-HsN3
assembly intermediates. The lack of mature HsN3 in
Smad1 immunoprecipitates does not reflect the inability
of Smad1 to bind prosequence-less HsN3, but is likely due
to either the trapping/degradation of Smad1 inside of the
proteasome, or the rapid dissociation of Smad1 from
HsN3. The degradation of Smad1 by proteasome is re-
ported in a separate study [39]. The dissociation of Smad1
from the mature 20S proteasome could be due to the
competition of Smad1 binding by a 19S regulator protein
or simply due to the inaccessibility of the binding site on
HsN3 when two half proteasomes assembly into the ma-
ture proteasome.
Two separate domains on Az mediate interaction with 
Smad1 and HsN3 prior to HsN3 incorporation into the 20S 
proteasome
We next examined the interaction between Az and Smad1
in COS1 cells. In the absence of the co-expressed HsN3,
Smad1 was co-precipitated with Az (Fig. 5A, top panel,
lane 1). The interaction was diminished when cells were
co-transfected with the activated BMP type I receptor
ALK3Q233D (Fig. 5A, top panel, lane 3). However, the
addition of proteasome inhibitor LLnL stabilizes the inter-
action (Fig. 5A, top panel, lane 2). Thus, Smad1 interacts
with Az in mammalian cells and the interaction is also en-
hanced upon BMP type I receptor activation. In the yeast
two-hybrid tests, we also observed the ability of Az to bind
HsN3 [39]. Domain mapping analyses of Az reveals two
separate domains on Az that are involved in binding to
Smad1 and HsN3 (Fig. 5B). In mammalian cells, co-ex-BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Figure 5
The formation of a ternary complex between Smad1, Az and HsN3.A. Az interacts with Smad1 and the interaction
is enhanced by receptor activation in the presence of lactacystin. COS cells were transfected with the indicated plasmids. F-
Smad1 was precipitated with anti-Smad1 monoclonal antibody and the co-precipitated F-Az was detected by anti-Flag Western
blot. "IgG.L." represents the IgG light chain. The total expression of the proteins in the lysates was detected by Western blot
as shown in the bottom panels. B. Results of domain mapping analyses of Az. Different deletion constructs of Az were made as
illustrated and subcloned into yeast expression vector pJG4-5, which were then co-transformed with full length LexA-Smad1
and LexA-HsN3 into yeast two-hybrid system. The interaction tests were carried out similarly as shown in Fig. 1. The separate
domains important for Az to bind HsN3 and Smad1 are indicated. C. Az interacts with both Smad1 and HsN3 when they are
co-expressed at a specific ratio. COS1 cells were co-transfected with the indicated constructs of Smad1, Az and HsN3. The
amount of DNA used for the transfection is also indicated. The co-precipitated Smad1 and Pro-N3-F are marked. D. A car-
toon to summarize the observed complex formation between Smad1, HsN3 and Az along the proteasome assembly pathway.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
Page 10 of 21
(page number not for citation purposes)
pression of Az with Smad1 and HsN3 leads to the detec-
tion of both Smad1 and Pro-N3 in the immunoprecipitates
of Az (Fig. 5C, top panel, lane 6). There appears to be a
stoichiomatric relationship between these three proteins,
since the relative levels of these three proteins influence
the interaction properties (Fig. 5C). These data suggest
that Smad1, Az and HsN3 might form a ternary complex.
Since we again only detected the pro-sequence form of
HsN3 in Az precipitates, such a ternary complex is likely
formed along the assembly pathways of HsN3.
The Activation of the BMP type I receptor induces Smad1-
dependent nuclear translocation of both HsN3 and Az
Smad1 is translocated from the cytoplasm to the nucleus
upon its activation by the BMP type I receptors [40]. The
physical interaction between Smad1, Az and HsN3 sug-
gests that BMP signaling might regulate the intracellular
localization of Az and HsN3. We tested the localization of
endogenous HsN3 in COS1 cell line, which was transient-
ly transfected with Smad1, ALK3 and the BMP type II re-
ceptor. Cells were either not exposed to BMP2 (Fig. 6A),
or treated with BMP2 for 30 mins (Fig. 6B) or 60 mins
(Fig. 6C). Cells were stained with a monoclonal anti-
HsN3 antibody and FITC-conjugated anti-mouse second-
ary (Fig. 6A,6B,6C, panels 1) and simultaneously with a
polyclonal anti-Smad1 antibody and rhodamine-conju-
gated anti-rabbit secondary antibody (Fig. 6A,6B,6C, pan-
els 2). The co-localization of Smad1 and HsN3 was
detected by overlaying the signals in panels 1 and panels
2 and shown in panels 3. Smad1 and HsN3 were detected
in both the cytoplasm and the nucleus in cells that were
not exposed to BMP2 (Fig. 6A, panels 1–3). In cells treated
with BMP2 for 30 mins, most HsN3 and Smad1 were con-
centrated in the nucleus (Fig. 6B, panels 1 & 2) and co-lo-
calization of Smad1 and HsN3 was detected in the
nucleus (Fig. 6B, panel 3). In cells treated with BMP2 for
60 mins, all signals of Smad1 and HsN3 were detected to
be co-localized in the nucleus (Fig. 6C, panels 1–3).
We further tested the role of Smad1 in the nuclear translo-
cation of HsN3. HsN3 was detected in speckled pattern
throughout the cytoplasm and the nucleus when it was ex-
pressed alone in COS1 cells (Fig. 6D, panel 1). Similar lo-
calization pattern was detected when HsN3 was co-
expressed with Smad1 (Fig. 6D, panel 2) or with
ALK3Q233D (Fig. 6D, panel 3). However, when HsN3
was co-expressed with both Smad1 and ALK3Q233D, the
majority of HsN3 signals were detected in the nucleus
(Fig. 6D, panel 4). Thus, the nuclear translocation of
HsN3 is dependent upon both the receptor activation and
the presence of Smad1. Similarly, the localization of Az is
also dependent upon the co-expression of Smad1 and the
activated BMP type I receptor (Fig. 6E, panels 1–4). When
Smad1 was replaced by Smad2, Az was found in both the
cytoplasm and the nucleus upon the co-expression of
ALK3Q233D (Fig. 6E, panel 4), although cytoplasmic sig-
nals of Az were slightly decreased. This could be due to the
presence of endogenous Smad1 in COS1 cells.
Thus, the localization of both Az and HsN3 is regulated by
the BMP type I receptor in a Smad1-dependent manner.
This data confirms the physical interaction between
Smad1, HsN3 and Az detected by immunoprecipitation
and further suggests that the cytoplasmic Smad1 forms a
complex with Az and HsN3 and brings these two proteins
into the nucleus upon the activation of BMP type I recep-
tor.
The novel CBP/p300 repressor SNIP1 is recruited to Az 
upon the activation of BMP type I receptor
The observed physical interaction between Smad1, HsN3
and Az and the regulation of the complex formation by
BMPs suggests a functional role of Az and HsN3 in the sig-
naling function of Smad1. In a separate study, we have
shown that Az and HsN3 play targeting roles in the pro-
teasomal degradation of Smad1 upon the activation of
BMP type I receptors [39]. The observed proteasomal deg-
radation of Smad1 upon the activation of BMP signaling
could simply serve to irreversibly terminate Smad1-medi-
ated signaling pathways of BMPs. However, we observed
that Az and HsN3 also interact with several isolated
Smad1 interactors. Furthermore, the nuclear co-transloca-
tion of Az and HsN3 with Smad1 also suggests potential
proteasomal targeting role of Az and HsN3 in the nucleus.
Thus, we tested the hypothesis that Az and HsN3 also tar-
get Smad1 interacting proteins in the nucleus.
Among the isolated Smad1 interactors shown in Fig. 1,
clone 19 encodes a novel nuclear protein named as
Smad1 Nuclear Interacting Protein-1 (SNIP-1). Our recent
studies suggested that SNIP1 is a novel CBP/p300 repres-
sor [25]. SNIP1, when expressed in COS1 cells, is entirely
localized to distinct areas within the nucleus (Fig. 7A). In-
terestingly, SNIP1 binds to Az and HsN3 in the yeast two-
hybrid system, in addition to its ability to bind Smad1
(Fig. 7B). SNIP1 and ODC exhibited similar affinity to Az
in the yeast two-hybrid test (Fig. 7B). Domain mapping
studies showed that the linker region of Smad1 was suffi-
cient to bind SNIP1 (Fig. 7C). To confirm the interaction
between SNIP1 and Az or HsN3 seen in the yeast two-hy-
brid system, we transfected COS1 cells with each pair of
proteins and tested the interactions by immunoprecipita-
tion assays. Upon the co-expression with SNIP1, the pre-
assembled form of HsN3 but not Az was co-precipitated
with SNIP1 (Fig. 7D, lanes 1 & 2). Since SNIP1 is a nuclear
protein, the interaction between SNIP1 and Az may re-
quire the nuclear translocation of Az. Based upon the ob-
servation that the nuclear translocation of Az is dependent
upon Smad1 and BMP type I receptor activation (Fig. 6E),
we therefore tested Az interaction with SNIP1 in the pres-BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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ence of the co-expression of Smad1, Smad4 and
ALK3Q233D. In the absence of ALK3Q233D, no F-Az was
detected in the precipitates of SNIP1 (Fig. 7E, top panel,
lane 2). However, the co-expression of ALK3Q233D al-
lowed the detection of F-Az in SNIP1 immunoprecipitates
(Fig. 7E, top panel, lane 3). A weak Smad1 signal but no
Smad4 signal was detected in SNIP1 immunoprecipitates.
Thus, in the mammalian overexpression system, the pre-
assembled HsN3 exhibits constitutive interaction with
SNIP1, whereas Az is only recruited to SNIP1 upon recep-
tor activation. The lack of strong signals of Smad1 or
Smad4 in the immunoprecipitates of SNIP1 in the pres-
ence of BMP type I receptor activation may be due to the
transient nature of the complex, which, as shown below,
is targeted to proteasome for degradation.
Figure 6
Smad1-dependent nuclear translocation of Smad1, HsN3 and Az in response to BMP type I receptor activa-
tion.A-C. Smad1 and HsN3 are both rapidly translocated from the cytoplasm to the nucleus in response to BMP2. COS cells
were transiently transfected with Smad1, ALK3 and BMPRII and were either not treated (A), or treated with BMP2 for 30 mins
(B), and 60 mins (C). Smad1 (red) and HsN3 (green) signals at each time point were detected and their co-localization shown
by overlaying HsN3 signals in panel "1" with Smad1 signals in panel "2" to yield panel "3". D. HsN3 nuclear translocation is
dependent upon the coexpression of Smad1 and the activation of the BMP type I receptor. COS cells were transfected with
the indicated plasmids. HsN3 was detected by anti-Flag monoclonal antibody and FITC conjugated anti-mouse secondary anti-
body. E. Az is also translocated to the nucleus in response to the activation of BMP type I receptor in a Smad1-dependent fash-
ion. COS cells were transfected with the indicated plasmids and stained with anti-Flag monoclonal antibody and FITC
conjugated anti-mouse secondary antibody. To maximize the details of intracellular localization of each protein, each panel only
shows the single cell-image that represents the localization patterns in more than 80% transfected cells.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
Page 12 of 21
(page number not for citation purposes)
Figure 7
A novel Smad1 Nuclear Interacting Protein (SNIP1) is recruited to interact with Az in a BMP receptor activa-
tion-dependent fashion.A. SNIP1 is a nuclear protein. COS1 cells were transfected with T7-tagged SNIP1. Anti-T7 mono-
clonal antibody and FITC conjugated anti-mouse secondary antibody was used to detect SNIP1. B. SNIP1 specifically interacts
with Smad1, Az and HsN3 but not with ODC in the yeast two-hybrid system. The panels labeled as "1" and "2" represent yeast
transformants on U-H-W- galactose or glucose plates, respectively. B42 fusion proteins were only induced in yeast grown on
galactose plates. C. Domain mapping of Smad1 interaction with SNIP1 in yeast. "Smad1GS" represents the mutant Smad1
(G419S) [40]. Smad1NL contains the MH1 and the linker region; Smad1L contains only the linker region. D. SNIP1 interacts
with the pro-sequence-containing form of HsN3 but not with Az in COS cells upon coexpression. COS cells were transfected
with the indicated plasmids. Cells were metabolically labeled with 35S-methionine for the last 4 hours before lysates were made
for immunoprecipitation. Az is marked by an asterisk in lane 6, while the two forms of HsN3 are marked as in previous Figures.
E. SNIP1 interacts with Az upon its co-expression with Smad1, Smad4 and the BMP type I receptor activation enhances the
interaction. COS cells were transfected with 2 µg each of the indicated plasmids. The anti-T7 immunoprecipitates were ana-
lyzed by Western blot with monoclonal anti-Flag (top panel). The co-precipitated F-Az is indicated (lane 3). Protein expression
was monitored by Western blot analyses of total lysates as shown in bottom panels.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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BMP type I receptor activation induces SNIP1 degradation 
that is regulated by Smad1, Smad4 and Az
To follow the observed reduction of SNIP1 level upon the
expression of high level of ALK3Q233D, as mentioned
above, we co-expressed SNIP1 together with Smad1,
Smad4, Az and high dose (6 µg) of either the wild type
ALK3 or the constitutive active ALK3Q233D. The protein
levels of each protein were analyzed by Western blot (Fig.
8A). A dramatic decrease of SNIP1 level was detected in
ALK3Q233D-transfected cells (Fig. 8A, panel 1, lanes 1 &
2). The receptor activation-induced decrease of SNIP1 is
partially sensitive to the proteasome-specific inhibitor lac-
tacystin, suggesting the involvement of proteasomal deg-
radation (Fig. 8A, panel 1, lane 3). The incomplete rescue
of SNIP1 level by lactacystin suggests the involvement of
additional mechanisms other than 26S proteasome in
SNIP1 degradation. To systematically demonstrate the
role of Smad1, Smad4 and Az in the observed decrease of
SNIP1 protein level, we sequentially left out one of these
three proteins in the above assay. The ALK3Q233D-in-
duced degradation of SNIP1 was significantly blocked in
the absence of Az (Fig. 8A, panel 1, lanes 4 & 5), Smad4
(lanes 6 & 7), or Smad1 (lanes 8 & 9). Thus, the
ALK3Q233D-induced degradation of SNIP1 is regulated
by the protein levels of Smad1, Smad4, Az and is only in-
duced by high dose of the activated BMP type I receptor.
Interestingly, by simply replacing Smad1 with the Smad1
mutant Smad1G419S [40], which is defective in binding
to BMP type I receptor for receptor-mediated phosphor-
ylation and the subsequent nuclear translocation, SNIP1
degradation was also inhibited (Fig. 8A, panel 1, lanes 10
& 11), suggesting that the degradation of SNIP1 is de-
pendent upon the type I receptor-mediated phosphoryla-
tion of Smad1. The levels of SNIP1 in Fig. 8A top panel are
quantified and plotted as Integrated Optical Density
(IOD) of SNIP1 (Fig. 8A, right panel).
We noted that the protein levels of Smad1, Smad4 and Az
were co-regulated with that of SNIP1. For example, the
protein levels of Smad1, Smad4 and Az were all sensitive
to lactacystin (Fig. 8A, all panels, compare lane 2 and lane
3). Blocking SNIP1 degradation was accompanied by in-
creased protein levels of Smad1, Smad4 and Az in cells ex-
pressing the activated ALK3 (Fig. 8A, lanes 5, 7, 9, 11). The
lower levels of Smad1, Smad4, Az and SNIP1 in lane 1
compared with those in lane 10 suggest that the leaky sig-
naling by the overexpressed ALK3, which we have demon-
strated recently [39], caused a constitutive reduction of
Smad4, Az and SNIP1 level that is dependent upon the ac-
tivation of Smad1. These data thus suggest that SNIP1 is
targeted to proteasome for degradation together with
Smad1, Az and Smad4.
The ability of Smad1 in regulating SNIP1 degradation was
further demonstrated by increased expression of Smad1 in
COS1 cells that were transfected with a constant amount
of Smad4, Az, ALK3Q233D and SNIP1 (Fig. 8B). A dose-
dependent effect of Smad1 on receptor-induced degrada-
tion of SNIP1 was observed (Fig. 8B, compare lanes 1 & 2
with lanes 5 & 6).
To confirm SNIP1 degradation in non-overexpression sys-
tems, we monitored the steady state levels of endogenous
SNIP1 in the human keratinocyte HaCaT and mouse my-
oblast L6. Cells were treated with BMP7 for different peri-
ods of time. Western blot analyses using an anti-SNIP1
antibody detected two forms of SNIP1 with slightly differ-
ent mobility, which are named as SNIP1.A and SNIP1.B
(Fig. 8C, top panel). The IOD of each form of SNIP1 as
well as the total IOD of both forms are plotted (Fig. 8C,
right panel). In HaCaT cells, the protein levels of both
forms of SNIP1 were significantly decreased after 3 hrs of
BMP7 treatment and were almost diminished by 22 hrs.
Interestingly, a different response was observed in L6 cells.
The levels of SNIP1 were somewhat increased after 3 hrs
and peaked at 3.5 hrs, but then started to decline at 7 hrs
and were diminished at 22 hrs.
SNIP1 is a nuclear repressor of the BMP-induced transcrip-
tion responses
To determine the functional significance of the observed
SNIP1 degradation induced by BMPs, we tested the role of
SNIP1 in Smad1-regulated gene responses of BMPs. We
first tested the effect of SNIP1 on the BMP-induced activa-
tion of the Tlx2 promoter, which involves Smad1 [41].
Full length SNIP1 exhibits dose-dependent inhibition of
the BMP-induced gene activation, as monitored by the lu-
ciferase activities (Fig. 9A). Thus, SNIP1 is an inhibitor of
BMP-induced gene response. Since we have previously
shown that SNIP1 binds and inhibits CBP/p300 via its N-
terminal domain [25], the deletion mutant of SNIP1 lack-
ing the CBP/p300 binding site, SNIP1 (142–369), was
tested in the same assay. SNIP1 (142–369) exhibits little
inhibitory activity towards the gene response (Fig. 9A, see
∆ N-SNIP1). This data further suggests that the inhibitory
activity of SNIP1 is mediated by its interaction with CBP/
p300, similar to what has been reported in the TGF-β
pathways [25]. We next tested the inhibitory activity of
SNIP1 on the transcriptional activity of Smad1, using the
GAL4-Smad1 and GAL4-Luc reporter system, as described
previously [42,43]. SNIP1 inhibited BMP-induced activa-
tion of GAL4-Luc in p19 cells transfected with GAL4-
Smad1 (Fig. 9B). The proteasome specific inhibitor lacta-
cystin also inhibited the BMP-induced GAL4-Smad1 tran-
scriptional activity (Fig. 9B), consistent with a role of
proteasomal degradation in Smad1-mediated transcrip-
tion. The effect of lactacystin is specific, since the control
reporter gene β -Gal was not inhibited by lactacystin (data
not shown). In a separate study, we also demonstrated
that proteasomal degradation also plays an essential roleBMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Figure 8
The activation of BMP type I receptor induces SNIP1 degradation which is co-regulated by Smad1, Smad4 and
Az.A. SNIP1 degradation is lactacystin-sensitive and is dependent upon the co-expression of Smad1, Smad4 and Az in COS
cell overexpression system. COS cells were transfected with the indicated plasmids. Lactacystin (10 µM) was added during the
last 10 hrs. The expression of each protein was detected by Western blot. Cell lysates were also blotted with a monoclonal
anti-α  tubulin, which served as a control for loading (bottom panel). "*" in lanes 10 and 11 represents the mutant Smad1
(G419S). This construct is T7 tagged, thus did not show on the anti-Flag blot (top panel). Its expression was confirmed by anti-
T7 on a separate blot (not shown). The right panel shows the Integrated Optical Density of SNIP1 obtained from quantification
of SNIP1 signals using Densitometry. B. Increased expression of Smad1 enhances SNIP1 degradation induced by BMP type I
receptor activation. COS1 cells were transfected with the indicated amount of DNA constructs of Smad1, Smad4, SNIP1, Az
and ALK3Q233D. The protein levels were detected by Western blot. The IOD of SNIP1 is plotted in the right panel. For both
panels, equal transfection efficiency was monitored by GFP and equal total protein loading was assured after protein concen-
tration measurement. C. The degradation of endogenous SNIP1 is induced in a time-dependent fashion by BMP7 in HaCaT and
L6 cells. HaCaT and L6 cells were treated with BMP7 (250 ng/ml) for the indicated time periods and cell lysates were separated
on SDS-PAGE then blotted by anti-SNIP1 polyclonal antibody [25]. Two different forms of endogenous SNIP1 are indicated as
SNIP1.A and SNIP1.B. The IOD of the combined IOD of these two forms are plotted in the right panel.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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in BMP induced dendritic formation of rat sympathetic
neurons [44].
Discussion
The bone morphogenetic proteins (BMPs) are multi-func-
tional regulators of early embryogenesis and tissue/organ
morphogenesis. Observations made in the past several
years suggest that a subset of Smad family proteins play
key roles in transmitting the signals of BMPs from the ac-
tivated receptors at the cell surface to the nucleus to regu-
late gene expression. Smad1, as one of the three known R-
Smads of BMPs, has been extensively studied within the
scope of its phosphorylation, interaction with Smad4, nu-
clear translocation, DNA binding and protein-protein in-
teractions related to its function as a transcriptional
regulator. Currently, Smad1 is regarded as a DNA-binding
transcriptional modulator that is activated by the BMP
type I receptors. Considering the sophisticated mode of
regulation characteristic of the TGF-β /BMP family ligands,
it is expected that that signaling mechanisms of Smads
should have a nature of complexity that can accommo-
date the vast biological functions of these regulators. We
took a discovery-driven approach to study the signaling
mechanism of Smad1, by systematically searching for pro-
teins that can physically interact with Smad1. Such an ap-
proach led to the identification of a set of proteins that can
specifically bind to Smad1. This report has focused upon
the functional characterization of two proteins that func-
tion along the degradation pathways of the 26S proteas-
ome: antizyme (Az) and HsN3.
Az was previously identified as a polyamine-inducible fac-
tor that binds and targets the ornithine decarboxylase
(ODC) to proteasome for degradation [18,45]. Until now,
ODC is the only protein known to be targeted by Az to
proteasome, although the existence of additional proteins
targeted by Az to proteasome has been suspected [20]. We
now find two new Az interactors: Smad1, the key signal
transducer of BMPs, as well as SNIP1, the nuclear repres-
sor of CBP/p300. In a separate study, we demonstrated
that Smad1 is targeted to proteasome for degradation, a
process involving the co-targeting role of Az and HsN3
[39]. Here we showed that SNIP1, after being recruited to
Az, is targeted, together with Smad1, to proteasome for
degradation. These data indicate that Az has a more gen-
eral role in targeting different substrates to proteasome for
degradation. However, unlike the known ability of Az to
bind ODC constitutively, the interaction between SNIP1
and Az is dependent upon the activation of BMP type I re-
ceptor and occurs in the presence of Smad1 and Smad4.
This suggests the existence of a novel BMP-regulated "con-
ditional" targeting activity of Az that is distinct from the
constitutive targeting activity of Az towards ODC.
HsN3 is one of the seven β  subunits of the 20S proteas-
ome, which is the catalytic core of the 26S proteasome
[22–24]. Besides its role as an indispensable component
of the 20S proteasome, HsN3 and the α  subunit HC9 of
Figure 9
SNIP1 is a nuclear repressor of Smad1-regulated
BMP-induced gene responses.A. Increased expression of
SNIP1 inhibits BMP-induced activation of the Tlx-2 reporter
gene. P19 cells were transfected with Tlx2-Luc reporter,
BMP type I receptor ALK2, the BMP type II receptor BMPRII
and different amount of SNIP1, as indicated. ∆ N-SNIP: a.a.
142–396, defective in binding to CBP/p300 [25]. BMP7 was
added at a final concentration of 250 ng/ml. The arbitrary
units of the luciferase activities of each group are presented
with error bars. The assays were carried out in triplicate, and
similar data were reproduced three times. B. Increased
expression of SNIP1 or lactacystin treatment both can inhibit
BMP-induced transcriptional activity of Smad1-GAL4 fusion
protein. P19 cells were transfected with GAL4-Smad1 and
GAL4-Luc. Cells were treated with BMP7 (250 ng/ml) 24 hrs
before lysates were made for luciferase assays. Lactacystin
was added 8 hrs before cells were harvested for the assay.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Figure 10
Mechanisms and functions of proteasomal targeting of Smad1 in signaling pathways of BMPs.A. A cartoon to
illustrate a novel mechanism for BMP-induced proteasomal targeting of Smad1 induced by BMPs. The activation of BMP type I
receptor enhances the interaction between Smad1 and two other proteins Az and HsN3. The newly synthesized HsN3 is in its
prosequence-containing form, which forms a ternary complex with Smad1 and Az. The assembly of HsN3 brings Smad1 and Az
to assembly intermediates (see step 3). The final maturation of the 20S proteasome may lead to the unfolding and trapping of
Smad1 inside the degradation chamber and the ultimate proteasomal degradation of Smad1. Alternatively, Smad1/Az complex
may be docked to a receptor of Az on 19S complex for the final delivery of Smad1 to proteasome for degradation. Two other
proteins, UMP1 and Hsp73, which are known to be associated with proteasome assembly intermediates, are also shown. Upon
the assembly of 20S proteasome, UMP1 is trapped inside of the 20S proteasome for degradation [46]. Hsp73 may play a role in
unfolding proteins [35]. B. A cartoon to illustrate proteasomal targeting of Smad1 as an integral event along the signaling path-
ways of BMPs. The activation of the BMP type I receptor is proceeded by type II receptor-mediated phosphorylation of the
type I receptor and by the dissociation of the cytoplasmic inhibitor FKBP12 from the type I receptor. The activated type I
receptor induces Smad1 phosphorylation and the subsequent formation of a complex of Smad1, Smad4, Az and HsN3, which is
in its pre-assembled form containing the prosequence. The complex is then translocated into the nucleus, where Smad1 and
Smad4 are recruited to specific DNA-binding sites near those of other DNA-binding transcription factors (DBs). In cells where
most of the CBP/p300 is bound to SNIP1, the removal of SNIP1 from CBP/p300 may be a critical step for the successful
recruitment of CBP/p300 to DBs. One way to remove SNIP1 could be via the recruitment of SNIP1 to Az and HsN3 in the
complex containing Smad1 and Smad4. The targeting of Smad1 to proteasome, as illustrated in panel A, could then mediate the
co-targeting of SNIP1 to proteasome for degradation. The removal of SNIP1 then allows the subsequent recruitment of CBP/
p300 to DBs for transcription. Possible cytoplasmic targeting of Smad1-containing complex via HsN3 assembly pathway is also
suggested. See text for details.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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the 20S proteasome have been shown to interact with the
viral protein Tax. This interaction was suggested to play a
role in Tax-induced proteasomal processing of the P105
subunit of NF-κ B [32]. Other proteasome integral compo-
nents, especially those in the 19S regulator of the 26S pro-
teasome, have also been shown to bring proteins to
proteasome for degradation [21]. Here we identified a
unique role of HsN3 in the Az-involved targeting pathway
that is coupled to BMP type I receptor activation. Our data
suggests that Smad1 and Az both interact with HsN3 only
before HsN3 is fully incorporated into the mature 20S
proteasome. We have shown that the reason for Smad1 to
only bind to the unprocessed form of HsN3 is not because
the prosequence contains a Smad1-binding site. Artificial-
ly removing the prosequence of HsN3 in fact allowed
Smad1 to stably bind to the prosequence-less HsN3 as
well as multiple proteins that are bound to the prose-
quence-less HsN3, which may represent the assembly in-
termediates that failed to reach maturation due to the lack
of HsN3 prosequence (Fig. 4D,4E,4F). These data collec-
tively point out the transient interaction between Smad1
and HsN3 along the assembly of HsN3 into the 20S pro-
teasome. So far, several proteins have been found to inter-
act with assembly intermediates of the 20S proteasome. A
small protein Ump1 associates with the premature protea-
some complexes and is shown to be involved in assisting
the maturation of 20S proteasome, possibly by interacting
with the β  rings of half proteasomes [46]. Upon the mat-
uration of the 20S proteasome, Ump1 is trapped inside
the proteasome and is degraded by proteasome [46]. The
HSP70 like chaperon protein Hsc73 also associates with
the 16S proteasome precursor complexes [35,36]. The ex-
act role of Hsc73 in 16S precursor proteasome complex is
not known, but has been suggested to assist proteasome
maturation [35,36]. Our studies add Smad1, Smad1 inter-
acting proteins such as SNIP1, Smad4, and Az as addition-
al proteins that associate with the assembly intermediates.
How does the association of HsN3 contribute to the final
degradation or processing of these proteins? Two possible
mechanisms are illustrated in Fig. 10A. The first possible
mechanism is via "Unfold and Trap". The proteasome as-
sembly intermediates could be a site for the entry of sub-
strates into the degradation chamber via an unfold-trap
mechanism that is coupled to the final maturation of the
20S proteasome. The chaperon proteins such as Hsc73
could be involved in unfolding the substrates for them to
fit into the degradation chamber and the final maturation
of 20S proteasome from the 16S assembly intermediates
could trap the substrates, such as Ump1 and Smads, in-
side the degradation chamber. If so, ubiquitination may
not be necessary for the degradation. This could be a com-
mon mechanism for ubiquitin-independent degradation
pathways. The second possible mechanism is via "docking
and delivery". HsN3 may simply bring the Smad/Az con-
taining complex close enough to the 26S proteasome and
then delivers it to the 19S complex via Az interaction with
its receptor within 19S regulator.
We have so far identified two functional outcomes of the
observed physical interaction between Smad1, HsN3 and
Az in the signaling pathways of BMPs. First, in a separate
report, we showed that Smad1 itself is targeted to protea-
some and is subsequently degraded by the proteasome, an
event that is triggered by the activation of BMP type I re-
ceptor and involves the targeting role of Az and HsN3
[39]. Proteasomal degradation of Smad1 appears to also
play a role in regulating the constitutive level of Smad1 in
cell as a way to adjust the cellular responsiveness of BMPs
[47]. However, the targeting mechanism and the regula-
tion involved in these two cases of Smad1 degradation by
proteasome are likely fundamentally different [39]. The
second functional outcome of the physical link between
Smad1, HsN3 and Az is the ability of Smad1 to regulate
the proteasomal degradation of SNIP1, which is clearly
dependent upon high levels of Smad1, Az and a strong ac-
tivation signal from the type I receptor, as suggested by the
observations that the protein levels of Smad1, Az and
ALK3Q233D directly influence the degree of SNIP1 degra-
dation. While the detailed mechanisms for such a novel
mode of regulation still requires many additional studies,
so far we observed several important steps that may con-
tribute to SNIP1 degradation. First, Smad1 binds both
HsN3 and Az in the cytoplasm and brings them into the
nucleus upon the activation of BMP type I receptor (Fig.
6). Second, SNIP1 is recruited to Az and HsN3, which are
likely in a complex with Smad1 and Smad4 (Fig. 7D &
7E). Third, SNIP1 is co-targeted into the proteasome with
Smad1, Smad4 and Az via the rapid assembly of HsN3
into the proteasome. This is suggested by the observations
that the targeting of SNIP1 is positively regulated by
Smad1 level and is dependent upon Smad1, Smad4 and
Az (Fig. 8A & 8B). Fourth, Smad4 is a positive regulator of
the targeting of SNIP1 to proteasome. The requirement of
both Smad1 and Smad4 in the down-regulation of SNIP1
is interesting since this may represent an important mo-
lecular mechanism for the co-operative property of these
Smads to modulate transcription. The functional signifi-
cance of SNIP1 degradation is apparent, since SNIP1 is a
constitutive interactor and functional repressor of the
master transcription co-activator CBP/p300 [25]. In the
BMP signaling pathways, SNIP1 is a potent inhibitor of
Smad-responsive genes via inhibiting CBP/p300 (Fig. 9A).
Thus the down-regulation of SNIP1 likely leads to the lib-
eration of CBP/p300 and directly contributes to the well-
known transcriptional modulator functions of Smad1
and Smad4. These ideas are summarized in a cartoon in
Fig. 10B. Specifically, the activated Smad1 and Smad4 en-
ter the nucleus, where Smad1 and Smad4 together recruit
SNIP1 and CBP/p300. The inhibition of SNIP1 on CBP/
p300 is considered to act through its interaction with theBMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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C/H1 domain of CBP/p300, thereby blocking the recruit-
ment of CBP/p300 by other transcription factors includ-
ing Smad4 [25]. Such an inhibition is counteracted by the
ability of Smad4 to compete off SNIP1 from CBP/p300
[25]. So at early phase of Smad activation, although
SNIP1 is still bound to Smad1 and Smad4, it is no longer
directly bound to CBP/p300, which now can activate tran-
scription. Our data suggested that the Smad1/Smad4
bound SNIP1 can be further targeted to proteasome for
degradation. Smad1 and Smad4 are indeed both degrad-
ed. However, we propose that such degradation is coupled
to the recruitment of the SNIP1-free CBP/p300 to a nearby
DNA-binding transcription factor, thus carrying out the
commonly observed role of Smads as transcriptional co-
modulators. Smads have been shown to mediate tran-
scription via modulating the transcriptional activity of
many other DNA-binding proteins. The ability of Smad1
and Smad4 to target SNIP1 for degradation, thereby free-
ing CBP/p300 for other transcriptional factors is likely an
important mechanism for the transcriptional modulator
role of these two Smads.
We have observed that several other Smad1 interactors,
including some cytoplasmic interactors of Smad1, are also
degraded by proteasome (Wang et al., unpublished data).
Thus, the location for the targeting of Smad1 may not be
limited to only inside of the nucleus, as illustrated in Fig.
10B. Future studies are needed to verify and enrich the de-
tails of the illustrated molecular events.
Conclusions
The subject of proteasomal degradation of Smads and
Smad interacting proteins has now become a major focus
of interest in the field due to its broad implication in sig-
naling regulation and execution. The work reported here
represents our major efforts during the past several years
to follow a novel concept of proteasomal degradation in
TGF-β /BMP signaling based upon the yeast two-hybrid
data obtained in 1996. Although there are multiple re-
ports on proteasomal degradation of Smads and Smad in-
teracting proteins, primarily in TGF-β  signaling pathways
[47–54], our observations reported here are entirely based
upon our own original observations and show a novel
connection of Smads with the proteasome system that no
other groups have reported. Our observations provide
new revenues for future understanding of the functional
mechanisms of Smads, which are likely not limited to
transcriptional regulation but are quite extensively linked
to the regulation of proteasomal degradation of multiple
cytoplasmic and nuclear proteins.
Materials and Methods
Construction of expression plasmids
For the yeast two-hybrid screen, full-length Smad1 was
subcloned into BamH1/Not1 sites of PEG202 by a PCR
method, resulting in the inframe fusion between the LexA
DNA binding domain (1–202) and Smad1. The Smad1
(G419S) mutant was a kind gift from J. Wrana [40]. The
subcloning of Smad1 (G419S), Smad1NL (1–271),
Smad1L (147–271) into pEG202 were all carried out sim-
ilarly by the PCR approach. The mammalian expression
constructs of Smad1 and its deletion mutant Smad1C
(271–465) were made by subcloning Smad1 into two
modified pCMV6 vectors, which have either the Flag
epitope (F-pCMV6) or the T7 epitope (T7-pCMV6) placed
upstream of an array of new multiple cloning sites. T7-
∆ N3 pCMV6 was made by PCR amplification of HsN3
(a.a. 45–263) followed by subcloning the PCR products
into the EcoR1/Xho1 sites of the modified T7-pCMV6 vec-
tor. N3-F pCMV6 was made by PCR amplification of
HsN3 (1–263) followed by subcloning the PCR products
into the EcoR1/EcoRV sites of pFlag-CMV5C vector (Ko-
dak). The fidelity of the PCR products was determined by
DNA sequencing. The constitutively active mutant BMP
type I receptor (ALK3Q233D) is a gift from J. Massagué;
Tlx-2 reporter is from J. Wrana; full length rat Az is from
P. Coffino.
Yeast two-hybrid screen and tests
A modified yeast two-hybrid system developed by Brent
and colleagues [26,27]. was used to isolate Smad1 interac-
tors. Briefly, yeast strain EGY48 (leu2, his3, trp1, ura3),
which has an integrated Leu2 reporter, was first trans-
formed with a LexAop-LacZ reporter. The selected trans-
formants were transformed again with the bait construct
Smad1pEG202. The selected bait transformants were
transformed with a human fetal brain cDNA library (a gift
from Roger Brent). About one million original transform-
ants were obtained. From the pooled stock of the trans-
formants, ten million cells were screened on U-H-W-L-
galactose plates containing X-Gal (5-bromo-4-chloro-3-
indolyl-β -D-galactosidase). Only those that form blue col-
onies were picked as candidate positives. The cDNAs from
the candidate positives were purified, re-tested for Smad1
interaction in yeast, and then sequenced. For testing pro-
tein-protein interaction using the yeast two-hybrid sys-
tem, the same yeast strain was first transformed with the
LexA-fusion construct, selected on U-H- plates, then re-
transformed with B42-fusion constructs, and selected on
U-H-W- plates. The transformants were first streaked onto
a master plate, then replicated onto two testing plates: U-
H-W- glucose plate with X-Gal and U-H-W- galactose/raffi-
nose plate with X-Gal. For presentation, yeast transform-
ants were also directly streaked onto U-H-W- galactose/
raffinose plate with X-Gal, after confirming lack of the
auto-activation on glucose plates.BMC Cell Biology 2002, 3 http://www.biomedcentral.com/1471-2121/3/15
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Transient transfection, 35S-metabolic labeling, immuno-
precipitation and western blot
Equal amount of total plasmids were used to transiently
transfect COS-1 using the DEAE dextran method [40]. A
GFP construct was used to monitor the transfection effi-
ciency. 293 cells were transfected by the standard CaPO4
procedure [55] and cells were harvested 24 hrs after tans-
fection. For metabolic labeling, cells were incubated with
250 µCi 35S-methionine per plate for 4 hrs, two days after
transfection. To make lysates, transfected cells were
washed with cold HBSS, scraped, lysed on ice in 300 µl
lysis buffer (20 mM Tris, PH 7.4, 150 mM NaCl, and 0.5%
Triton X-100, 1mM EDTA) containing protease inhibitors.
Protein expression level was determined by Western blot
analyses of 20 µl lysates before any immunoprecipitation
assays. For immunoprecipitation, 150 µl cell lysates were
pre-cleaned by protein A sepharose beads (Pharmacia),
incubated with 3 µl of anti-T7 (1 mg/ml) or anti-Flag (3
mg/ml) (M2 monoclonal, IBI, Eastman Kodak) on ice
overnight. Protein A (for anti-T7) and protein G (for anti-
Flag) sepharose beads were used to absorb the antibodies.
After washing, beads were treated with protein sample
buffer to elute immunoprecipitates. Eluted proteins were
separated on SDS-PAGE. The detection of the co-precipi-
tated proteins was carried out either by autoradiography,
if proteins were metabolically labeled or by Western blot
using the ECL kit. When proteasome inhibitors were ap-
plied, the inhibitors LLnL (50 mM in DMSO) or lactacys-
tin (10 mM in H2O) were added directly to the cell
medium at 1:1000 dilutions. Lactacystin was purchased
from E. J. Corey laboratory at Harvard University. LLnL
was purchased from Sigma.
Immunocytochemistry and confocal microscopy
Immunocytochemistry was carried out as described previ-
ously [40]. Briefly, COS cells were grown to 50% conflu-
ency on gelatin-coated glass cover slips. Cells were
transiently transfected with the indicated plasmids (total
10 µg) using the DEAE dextran method. About 48 hrs after
transfection, cells were fixed in 4% paraformaldehyde for
10 min, and then permeablized with methanol for 2
mins. Cells were blocked in 10% goat serum/PBS for 1 hr
at room temperature, before the sequential incubation
with the primary and secondary antibodies. The mono-
clonal anti-HsN3 (MCP444) is a gift from K. B. Hendil.
The polyclonal anti-Smad1 antibody is a gift from A. Rob-
erts. The secondary antibodies were either FITC-conjugat-
ed, or Rodamine-conjugated goat anti-mouse IgG
(Jackson ImmunoResearch, Westgrove PA).
Confocal Microscopy was carried out on a Leica TCS 4D
Confocal Laser Scanning Microscope at the Schepens Eye
Research Institute (Boston MA).
Luciferase assays
P19 cells were seeded in 100 mm dish and cultured for 24
hrs before they were transfected with luciferase reporter
constructs using Fugene Kit (Roche). Each group of trans-
fected cells was re-seeded into eight separate wells in a 24-
well plate 18 hrs after transfection. Eighteen hrs after re-
seeding, cells were washed twice with 1 ml serum-free me-
dia and left in 200 µl media. Four out of eight dishes of
each group were exposed to BMP7 (25 ng/ml BMP7),
which was directly added into the media for 24 hrs. Cul-
ture media was then removed and 100 µl of Reporter Lysis
Buffer (Promega 5X stock, diluted with H2O) was added
to the cells, which were then frozen at -80°C for 3 hrs. The
plates were thawed and 70 µl of supernatant was trans-
ferred to luciferase plates, mixed with 70 µl of luciferase
reagent (Promega). The luciferase activity was detected on
Wallac Victor 1420 plate reader. To normalize data, cells
were also transfected with β -Gal reporter and the β -galac-
tosidase activities measured using the Galacto-star kit
(Tropix, BM300S).
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